AKT1 and neoplasm: Overall, the current data show multiple targets of ZR30 for its tumor suppressive effect, including membrane receptors (EGFR, NOTCH1) and their downstream AKT-signaling, pro-invasive and pro-angiogenic extracellular protease (MMP2), and oncogenic transcription factor (FOXM1).